Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, ...

Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

Several new treatment options for patients with breast cancer have emerged over the last few years, including more oral ...

Formerly believed to predominantly affect Caucasians, new research indicates that MS actually may hit Blacks the hardest.

Researchers at the University of Colorado Anschutz Medical Campus have uncovered a promising breakthrough in the <a ...

The agreement will allow Enigma to use its PET imaging tracer PMI04 to visualize microglia activity in neurodegenerative ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

Officials say a new law to decrease the number of people being jailed solely because they need mental health treatment has ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

The most rigorous academic analysis to date of the research backing puberty blockers and cross-sex hormones as treatments for ...